STRIDES PHARMA SCI LTD
Latest filings
Next results: Thu, 29 Oct · Financial Results- Strides Pharma schedules earnings call for October 30, 2026 · Board & Shareholder Meetings
- Board to approve results for quarter and half year ended September 30, 2026 · Results
- Routine compliance filing for share demat details for Sep 2026 quarter · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
A Pharmaceuticals & Biotechnology company listed on NSE and BSE, reporting revenue of ₹5,004 Cr over the trailing twelve months.
Scorecard
Measured from the filed financials, judged against its Pharmaceuticals peers · as of FY26 — not investment advice
Strengths
Concerns
Charts
How has the market priced it — with filings on the timeline?
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from STRIDES PHARMA SCI LTD's filed financials and exchange disclosures
What does STRIDES PHARMA SCI LTD do?
STRIDES PHARMA SCI LTD is a Pharmaceuticals & Biotechnology company listed on NSE and BSE, trading under the symbol STAR.
Is STRIDES PHARMA SCI LTD profitable?
Yes. Over the trailing twelve months STRIDES PHARMA SCI LTD reported a net profit of ₹634 Cr on revenue of ₹5,004 Cr.
Does STRIDES PHARMA SCI LTD pay a dividend?
Yes. The dividend yield is 0.37% at the current price. It paid out 6% of its profit as dividend in FY26.
Is STRIDES PHARMA SCI LTD debt-free?
No. It reported borrowings of ₹1,669 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹1,480 Cr after cash. Debt stands at 0.53× equity. That is higher than 84% of its 166 Pharmaceuticals peers.
Is STRIDES PHARMA SCI LTD expensive compared with its peers?
On trailing P/E, STRIDES PHARMA SCI LTD ranks 37 of 158 in Pharmaceuticals — cheaper than 77% of them, against an industry median of 30.8×. This is a position, not a valuation judgement.
How much does the STRIDES PHARMA SCI LTD share price move in a day?
On a typical session STRIDES PHARMA SCI LTD moves 1.12% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
When are STRIDES PHARMA SCI LTD's next results?
Financial Results on Thu, 29 Oct. MarketPing alerts you on WhatsApp the moment the filing lands.
Where can I track STRIDES PHARMA SCI LTD's announcements?
Every NSE and BSE filing by STRIDES PHARMA SCI LTD appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.